Results 1 to 20 of 38
Page 1 of 2  Next >
TypeTitleAuthor(s)YearViews
Roles of paroxetine and corticosterone on adult mammalian ciliary body cell proliferationWang, H; Lau, BWM; Yau, SY; Li, SY; Leung, N; Wang, NL; Tang, SW; Lee, T; So, KF2010227
 
Entecavir (ETV) therapy in chronic hepatitis B patients previously treated with adefovir (ADV) with incomplete response on-treatment or relapse off-treatment.Lai, CL; Elion, R; Sherman, M; Hann, HW; Tyrell, DL; Hsu, CW; Tan, CK; Peng, CY; Leung, N; Mercarni, K; Zhang, H; Iloeje, UH; Kreter, B2009255
 
2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis BLiaw, Y; Gane, E; Leung, N; Zeuzem, S; Wang, Y; Lai, CL; Heathcote, EJ; Manns, M; Bzowej, N; Niu, J; Han, S; Hwang, SG; Cakaloglu, Y; Tong, MJ; Papatheodoridis, G; Chen, Y; Brown, NA; Albanis, E; Galil, K; Naoumov, NV20091,845
 
Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovirLeung, N; Peng, CY; Hann, HW; Sollano, J; LaoTan, J; Hsu, CW; Lesmana, L; Yuen, MF; Jeffers, L; Sherman, M; Min, A; Mencarini, K; Diva, U; Cross, A; Wilber, R; LopezTalavera, J2009420
 
Prolonged efficacy and safety of 3 years of continuous telbivudine treatment in pooled data from globe and 015 studies in chronic hepatitis B patientsHsu, CW; Chen, YC; Liaw, YF; Gane, E; Manns, M; Zeuzem, S; Wang, Y; Lai, CL; Hou, J; Leung, N; Bzowej, N; Niu, J; Jia, J; Hwang, SG; Cakaloglu, Y; Ren, H; Papatheodoridis, G; Chen, Y; Bao, W; Lopez, P2009323
 
Mutational analysis of 65 Wilson disease patients in Hong Kong Chinese: Identification of 17 novel mutations and its genetic heterogeneity (Journal of Human Genetics (2008) 53 (55-63) DOI: 10.1007/s10038-007-0218-2)Mak, CM; Lam, CW; Tam, S; Lai, CL; Chan, LY; Fan, ST; Lau, YL; Lai, ST; Yuen, P; Hui, J; Fu, CC; Wong, KS; Mak, WL; Tze, K; Tong, SF; Lau, A; Leung, N; Hui, A; Cheung, KM; Ko, CH; Chan, YK; Ma, O; Chau, TN; Chiu, A; Chan, YW2008155
 
Mutational analysis of 65 Wilson disease patients in Hong Kong Chinese: Identification of 17 novel mutations and its genetic heterogeneityMak, CM; Lam, CW; Tam, S; Lai, CL; Chan, LY; Fan, ST; Lau, YL; Lai, JY; Yuen, P; Hui, J; Fu, CC; Wong, KS; Mak, WL; Tze, K; Tong, SF; Lau, A; Leung, N; Hui, A; Cheung, KM; Ko, CH; Chan, YK; Ma, O; Chau, TN; Chiu, A; Chan, YW2008227
 
Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complicationsHui, CK; Leung, N; Shek, WH; Zhang, HY; Luk, JM; Poon, RTP; Lo, CM; Fan, ST; Lau, GKK200888
 
Changes in liver histology as a surrogate endpoint of antiviral therapy for chronic HBV can predict progression to liver complicationsHui, CK; Leung, N; Shek, TWH; Zhang, H; Luk, JMC; Poon, RTP; Lo, CM; Fan, ST; Lau, G2008113
 
Errata: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateLiaw, YF; Leung, N; Kao, JH; Piratvisuth, T; Gane, E; Han, KH; Guan, R; Lau, GKK; Locarnini, S; The Chronic Hepatitis B Guideline Working Party of the Asian-Pacific Association for the Study of the Liver2008130
 
Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patientsHui, CK; Leung, N; Shek, TWH; Yao, H; Lee, WK; Lai, JY; Lai, ST; Wong, WM; Lai, LSW; Poon, RTP; Lo, CM; Fan, ST; Lau, GKK2007177
 
Serum adiponectin is increased in advancing liver fibrosis and decline with reduction in fibrosis in chronic hepatitis BZhang, H; Hui, CK; Lee, PY; Chan, W; Yueng, YH; Leung, KW; Lu, L; Leung, N; Lo, CM; Fan, ST; Luk, JMC; Xu, A; Lam, KSL; Kwong, YL; Lau, G2007224
 
Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis BHui, CK; Zhang, HY; Lee, NP; Chan, W; Yueng, YH; Leung, KW; Lu, L; Leung, N; Lo, CM; Fan, ST; Luk, JM; Xu, A; Lam, KS; Kwong, YL; Lau, GKK2007147
 
Erratum: Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiretroviral therapy (Journal of Clinical Microbiology (2006) 44, 8 (2983-2987))Hui, CK; Bowden, S; Zhang, HY; Wong, A; Lewin, S; Rousseau, F; MommejaMarin, H; Lee, NP; Luk, JM; Locarnini, S; Leung, N; Naoumov, NV; Lau, GKK200757
 
The use of transient elastography as a preoperative assessment of hepatic resection (Abstract)Lai, L; Hui, CK; Poon, RTP; Shek, TWH; Lai, ST; Lai, JY; Lo, CM; Fan, ST; Leung, N; Lau, G2007105
 
Entecavir (ETV) Results in Higher HBV-DNA Reduction vs Adefovir (ADV) In Chronically Infected HBeAg(+) Antiviral-Naive Adults: 48-Week Results (E.A.R.L.Y. STUDY)Leung, N; Sherman, M; Peng, CY; Sollano, JD; Lesmana, L; Yuen, RMF; Jeffers, L; Hann, HW; Menearini, K; Colonno, R; Cross, A; Wilber, R; Lopez-Talavera, JC200798
 
Role of regulatory T cells in natural immunity and sustained pharmacological control of chronic hepatitis B infectionHui, CK; Zhang, HY; Lee, PY; Mommeja-Marin, H; Yueng, YH; Leung, KW; Lu, L; Leung, N; Luk, JMC; Naoumov, NN; Huang, FP; Lau, G2006102
 
Rituximab increases the risk of de novo hepatitis B infection in hepatitis B surface antigen negative patients undergoing cytotoxic chemotherapyHui, CK; Cheung, WW; Zhang, H; Au, WY; Yueng, YH; Leung, AYH; Leung, N; Luk, JMC; Lie, AKW; Kwong, YL; Liang, RHS; Lau, G2006169
 
Kinetics and Risk of De Novo Hepatitis B Infection in HBsAg-Negative Patients Undergoing Cytotoxic ChemotherapyHui, CK; Cheung, WWW; Zhang, HY; Au, WY; Yueng, YH; Leung, AYH; Leung, N; Luk, JM; Lie, AKW; Kwong, YL; Liang, R; Lau, GKK200695
 
Comparison of real-time PCR assays for monitoring serum HBV DNA levels during antiviral therapyZhang, HY; Hui, CK; Wong, A; Lee, NP; Leung, N; Luk, JM; Lau, GKK2006155
 
Page 1 of 2  Next >
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download